Variant report
Variant | esv3352977 |
---|---|
Chromosome Location | chr7:124863816-124866914 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536651390 | chr7:124863828-124863829 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376947362 | chr7:124863837-124863838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183496309 | chr7:124863859-124863860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73440528 | chr7:124863861-124863862 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187962341 | chr7:124863863-124863864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575412014 | chr7:124863917-124863918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543975004 | chr7:124863938-124863939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560655047 | chr7:124863958-124863959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529703972 | chr7:124863975-124863976 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190534481 | chr7:124864004-124864005 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563880726 | chr7:124864006-124864007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386717510 | chr7:124864007-124864008 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78920454 | chr7:124864008-124864009 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537883755 | chr7:124864009-124864010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62477080 | chr7:124864010-124864011 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1902003 | chr7:124864096-124864097 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs114471746 | chr7:124864103-124864104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75389599 | chr7:124864136-124864137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567769330 | chr7:124864195-124864196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73440532 | chr7:124864227-124864228 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs553170873 | chr7:124864267-124864268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566894459 | chr7:124864283-124864284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77867117 | chr7:124864309-124864310 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73440534 | chr7:124864330-124864331 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs545707304 | chr7:124864333-124864334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34986417 | chr7:124864385-124864386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs151168725 | chr7:124864433-124864434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544014091 | chr7:124864453-124864454 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554386221 | chr7:124864454-124864455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373769251 | chr7:124864479-124864480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574291432 | chr7:124864516-124864517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369367851 | chr7:124864519-124864520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114117906 | chr7:124864520-124864521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532860963 | chr7:124864618-124864619 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183056694 | chr7:124864653-124864654 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187029095 | chr7:124864676-124864677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545451533 | chr7:124864683-124864684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77370819 | chr7:124864700-124864701 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs398095356 | chr7:124864702-124864703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140150086 | chr7:124864754-124864755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531189159 | chr7:124864780-124864781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150326847 | chr7:124864784-124864785 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574325952 | chr7:124864951-124864952 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567904489 | chr7:124864986-124864987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542310203 | chr7:124865096-124865097 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192993615 | chr7:124865100-124865101 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150901010 | chr7:124865102-124865103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184341127 | chr7:124865117-124865118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112043460 | chr7:124865125-124865126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs145247901 | chr7:124865135-124865136 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20858243 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:124858200-124864000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr7:124862200-124864400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr7:124862400-124866200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr7:124863000-124864200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr7:124863200-124864600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr7:124863400-124864200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr7:124863600-124864200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr7:124863800-124864200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
9 | chr7:124864000-124864200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr7:124864200-124864400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr7:124864200-124865000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr7:124864200-124865200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr7:124864400-124864800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr7:124864400-124865200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
15 | chr7:124864600-124865200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr7:124864800-124865200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr7:124865000-124865400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr7:124865200-124865400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr7:124865200-124865400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr7:124865400-124866400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
21 | chr7:124865400-124869600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |